Keys And Regulators Of Nanoscale Theranostics 

Nanomaterials: Tools, Technology, and Methodology of Nanotechnology-Based Biomedical Systems for Diagnostics and Therapy

“…Here, the combination of diagnostics and therapeutics, in the form of nanomaterial-derived theranostics, seems to be a promising avenue to precisely target malignancies at the cellular level and deliver tailored treatments to the appropriate recipient, thus, reducing patients' burden caused by high-dosage application of pharmaceutical remedies. All these approaches, however, hinge on a full understanding of all aspects of cancer biology, such as the biology of oncogenes and tumor-suppressors and the role of the tumor environment in the genesis and the progression of cancers, as well as the influence of hypoxia exerted on the properties of cancers (see [62][63][64] and references therein as guides to principles and recent advantages).…”

Nanomaterials: Tools, Technology, and Methodology of Nanotechnology-Based Biomedical Systems for Diagnostics and Therapy

“…Here, the combination of diagnostics and therapeutics, in the form of nanomaterial-derived theranostics, seems to be a promising avenue to precisely target malignancies at the cellular level and deliver tailored treatments to the appropriate recipient, thus, reducing patients' burden caused by high-dosage application of pharmaceutical remedies. All these approaches, however, hinge on a full understanding of all aspects of cancer biology, such as the biology of oncogenes and tumor-suppressors and the role of the tumor environment in the genesis and the progression of cancers, as well as the influence of hypoxia exerted on the properties of cancers (see [62][63][64] and references therein as guides to principles and recent advantages).…”

Nanomaterials—Tools, Technology and Methodology of Nanotechnology Based Biomedical Systems for Diagnostics and Therapy

“…Here, the combination of diagnostics and therapeutics, in the form of nanomaterial-derived theranostics, seems to be a promising avenue to precisely target malignancies at the cellular level and deliver tailored treatments to the appropriate recipient, thus, reducing patients’ burden caused by high-dosage application of pharmaceutical remedies. All these approaches, however, hinge on a full understanding of all aspects of cancer biology, such as the biology of oncogenes and tumor-suppressors and the role of the tumor environment in the genesis and the progression of cancers, as well as the influence of hypoxia exerted on the properties of cancers (see [ 62 , 63 , 64 ] and references therein as guides to principles and recent advantages).…”